z-logo
Premium
How well are the optimal serum 25OHD concentrations reached in high‐dose intermittent vitamin D therapy? a placebo‐controlled study on comparison between 100 000 IU and 200 000 IU of oral D 3 every 3 months in elderly women
Author(s) -
Välimäki VilleValtteri,
Löyttyniemi Eliisa,
Pekkarinen Tuula,
Välimäki Matti J.
Publication year - 2016
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/cen.13014
Subject(s) - placebo , endocrinology , medicine , vitamin d and neurology , pathology , alternative medicine
Summary Objective Intermittent dosing may improve adherence to vitamin D therapy. Dosing regimen should maintain optimal serum 25‐hydroxyvitamin D (25 OHD ) levels over all the year. We compared two dosing regimens, the primary outcome being the percentage of 25 OHD measurements reaching the targets of 75 nmol/l or 50 nmol/l after baseline. Design Randomized, placebo‐controlled parallel group comparison. Patients Sixty women aged 75·0 ± 2·9 years. Interventions 100 000 IU (group 1D) or 200 000 IU (2D) of vitamin D 3 or placebo orally every 3 months plus calcium 1 g daily for 1 year. Measurements Serum 25 OHD , 1,25‐dihydroxyvitamin D, PTH , sclerostin, ionized calcium, urinary calcium, renal function, bone turnover markers. Results Serum 25 OHD increased, but the difference between two doses was of borderline significance ( P = 0·0554; area under curve analysis). Immediate postadministrative increases were higher in the 2D vs 1D group ( P < 0·05) after 3 and 6 months’ dosing. In the 1D and 2D groups, 51·2% and 57·7% of all on‐treatment measurements reached the target of 75 nmol/l. PTH levels differed marginally ( P = 0·0759) due to tendency to lowering immediately after vitamin D boluses. Urinary calcium differed between the groups ( P = 0·0193) due to increases 1 week after vitamin D dosing. Conclusions The doses of 100 000 or 200 000 IU of oral cholecalciferol every 3 months were not capable of stabilizing 25 OHD levels over the target of 75 nmol/l over the year. To improve the efficacy of high‐dose vitamin D therapy, the interval between boluses has to be shortened instead of increasing their size.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here